A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients
Clinical trial NCT02096601 · COMPLETED
Trial details
- NCT number
- NCT02096601
- Sponsor
- NeuroDerm Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-11
- Primary completion
- 2015-03-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.